Cite
HARVARD Citation
Felip, E. et al. (2021). Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer. Clinical pharmacology in drug development. 10 (10), pp. 1142-1155. [Online].